Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Apr 19, 2024 1:36pm
51 Views
Post# 35998422

RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an

RE:RE:RE:RE:CEO said, "we are undervalued". Okay, so how what is an
QContinuum1 wrote: As I've said before, nothing would tell the market that LABS is a player more than taking a part of the current cash reserve and doing a buyback at near all time lows.

You wanna prove that management believes profitability is a whisker away, do a buyback because we'll have money coming in anyhow.

You wanna prove that management is aware of the massive float and won't screw existing (and new) shareholders with a RS, do a buyback to reduce the float and prove a RS isn't necessary.

We have $18mil give or take in the bank, use half of it to do a share buyback at 0.08c.  Pretty sure existing shareholders would enjoy a 25% uplift in SP.

If half is too rich, do a quarter, but either way, it certainly would look very good and at this point if LABS is looking for good optics, this is a very easy way.




that tells me they have a problem putting their own money where their mouths are....

if they did that it fullfills all your points as well as the shares held by them would essentially be off the market as well a no brainer if they know oodles of money ids coming in ans SP will go up...

using company money to do a share buyback in essence uses shareholders money to achieve this, I am not opposed to doing share buyback at some point in the future but a possible M&A opportunity may create more value in the short tearm, and as everyone knows with cash you get a better deal. Plus you dont float shares to do the buying.

but hey to each their own
<< Previous
Bullboard Posts
Next >>